Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic sclerosis: current views of its pathogenesis.

Chris T Derk1, Sergio A Jimenez

  • 1Department of Medicine, Division of Rheumatology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Autoimmunity Reviews
|July 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pruritus associated with systemic sclerosis: a systematic review of treatment-based clinical trials.

Rheumatology international·2026
Same author

Stress exposure prior to diagnosis and clinical characteristics in systemic lupus erythematosus: a cross-sectional study.

Rheumatology international·2026
Same author

High mobility group motif proteins' role in fibrosis, inflammation, and vascular injury in systemic sclerosis.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

Systemic sclerosis and primary biliary cholangitis: a systematic review of case-control studies comparing isolated and overlapping disease phenotypes.

Journal of scleroderma and related disorders·2026
Same author

Transcatheter Aortic Valve Replacement in Systemic Sclerosis: A Case Series and Review of Short- and Long-Term Outcomes.

Mediterranean journal of rheumatology·2026
Same author

Systemic Sclerosis-Associated Interstitial Lung Disease: Improved Understanding and Advances in Management.

British journal of hospital medicine (London, England : 2005)·2025
Same journal

Reflections on chromatin structures, corresponding autoantibodies - And conflicting dogmas impacting pathogenesis of lupus nephritis.

Autoimmunity reviews·2026
Same journal

Cancer-associated dermatomyositis: A scoping review of the literature.

Autoimmunity reviews·2026
Same journal

The landscape of serum autoantibodies in lupus nephritis.

Autoimmunity reviews·2026
Same journal

Altered reproductive hormone profiles in systemic lupus erythematosus - A systematic review and meta-analysis.

Autoimmunity reviews·2026
Same journal

Decoding gut microbiome alterations in celiac disease: Implications for pathogenesis and treatment.

Autoimmunity reviews·2026
Same journal

Rethinking immunosuppression in limited cutaneous systemic sclerosis. The lcSSc conundrum; pros and cons for a timely immunosuppressive treatment.

Autoimmunity reviews·2026
See all related articles

Systemic sclerosis (SSc) is a severe autoimmune fibrotic disorder with high mortality. Understanding its pathogenesis is key to developing effective therapies for this incurable condition.

Area of Science:

  • Immunology
  • Rheumatology
  • Pathology

Background:

  • Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis, microvascular damage, and immune system abnormalities.
  • The etiology of SSc remains unknown, contributing to its progressive nature and high morbidity and mortality.
  • Clinical presentation of SSc is highly variable, ranging from limited skin involvement to severe multi-organ fibrosis.

Purpose of the Study:

  • To elucidate the underlying pathogenesis of Systemic Sclerosis.
  • To identify key mechanisms driving fibrosis and microvascular alterations in SSc.
  • To provide a foundation for developing targeted therapies for SSc.

Main Methods:

  • Review of existing literature on SSc pathogenesis.
  • Analysis of immunological and fibrotic pathways implicated in SSc.

Related Experiment Videos

  • Correlation of pathological findings with clinical manifestations and outcomes.

    • Main Results:

    • SSc involves complex interactions between immune cells, fibroblasts, and the microvasculature.
    • Progressive fibrosis in skin and internal organs is a hallmark of SSc.
    • Microvascular damage significantly contributes to SSc severity and patient outcomes.

    Conclusions:

    • Further understanding of SSc pathogenesis is crucial for therapeutic advancements.
    • Targeting fibrotic and microvascular pathways may offer new treatment strategies for SSc.
    • Research into the autoimmune mechanisms of SSc is essential for improving patient prognosis.